Kiek dividendų moka Excelsior Medical Co 2024?
Pagal paskutinę informaciją nuo lapkritis 2024, Excelsior Medical Co per paskutinius 12 mėnesių mokėjo bendrą dividendą, kuris sudarė 3,48 TWD už akciją. Esant dabartiniam Excelsior Medical Co kursui 86,90 TWD, tai atitinka 4,00 % dividendų grąžą.
Dividendai mokami kartus per metus.
4,00 % Dividendo grąža | = | 3,48 TWD Dividendas | 86,90 TWD akcijų kaina |
|
Ar Excelsior Medical Co dividendai yra saugūs?
Excelsior Medical Co kasmet didina dividendus jau 1 metus.
Per pastaruosius 10 metus Excelsior Medical Co kasmet 6,200 % padidėjo.
Per 5 metų laikotarpį augo išmokos padidėjo 5,496 %.
Analitikai prognozuoja, kad einamaisiais verslo metais Dividendų didinimas bus 0,565%.
Excelsior Medical Co Aktienanalyse
Ką daro Excelsior Medical Co?
Excelsior Medical Co Ltd was founded in Hong Kong in 1990 and has since become a leading provider of medical products and solutions for the healthcare sector worldwide. The company aims to offer innovative, reliable, and high-quality products that contribute to increasing efficiency and effectiveness in healthcare.
Since its establishment, Excelsior Medical Co Ltd has specialized in various business areas, including the production of surgical instruments and medical devices. Additionally, the company also provides services in the field of medical technology, including consulting, installation, and maintenance of medical devices.
The company prides itself on developing and manufacturing innovative products that are in line with the latest innovations and technologies. Excelsior Medical Co Ltd works closely with leading medical research institutes and experts to ensure that their products meet the highest standards.
Excelsior Medical Co Ltd's product portfolio includes a variety of products and solutions for the healthcare sector that are used by hospitals and medical facilities worldwide. These products include surgical instruments, anesthesia devices, patient monitoring devices, infusion systems, ventilators, and more.
Excelsior Medical Co Ltd is also involved in the manufacturing of consumables for medical facilities. These products include items such as disposable syringes, blood collection tubes, infusion sets, catheters, and other medical devices that have high quality and durability.
As a global company, Excelsior Medical Co Ltd has branches and subsidiaries in countries around the world, including China, USA, Europe, and Southeast Asia. This allows the company to provide support and service to its customers worldwide.
Overall, the company has gained a reputation as a trusted and reliable partner in the medical industry. Its products and solutions are valued by medical professionals in hospitals, clinics, and care facilities worldwide.
Excelsior Medical Co Ltd continues to prioritize innovation and technology in order to offer its customers the best possible products and solutions for the healthcare sector. The company aims to apply its experience and expertise in collaboration with medical experts and research institutions to develop new products and services. This allows them to continue meeting the growing demands of the healthcare industry. Excelsior Medical Co yra viena populiariausių įmonių Eulerpool.com svetainėje.Akcijų taupymo planai siūlo patrauklią galimybę investuotojams ilgalaikėje perspektyvoje kurti turtą. Vienas pagrindinių privalumų yra vadinamasis vidutinės išlaidos efektas: reguliariai investuojant fiksuotą sumą į akcijas arba akcijų fondus, automatiškai perkama daugiau dalinių vertybių popierių, kai kainos yra žemos, ir mažiau – kai jos aukštos. Tai gali lemti palankesnę vidutinę dalies kainą per laiką. Be to, akcijų taupymo planai suteikia galimybę ir smulkiesiems investuotojams patekti į brangias akcijas, nes jie gali dalyvauti jau su mažomis sumomis. Reguliarus investavimas taip pat skatina disciplinuotą investavimo strategiją ir padeda išvengti emociškai pagrįstų sprendimų, pavyzdžiui, impulsyvaus pirkimo ar pardavimo. Be to, investuotojai gauna naudos iš potencialaus akcijų vertės augimo bei iš dividendų, kurie gali būti reinvestuoti, kas sustiprina sudėtinio palūkanų efektą ir taip skatina investuoto kapitalo augimą.